Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Pancreatic Neoplasms × Losartan × Clear all

Phase

Status

Terminated 2 Active not recruiting 2 Withdrawn 1 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Radiation Fibrosis Syndrome 1 Pancreatic Neoplasms 1 Lung Neoplasms 1 Dyspnea 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 26 Taxes 9 Capecitabine 7 Albumin-Bound Paclitaxel 6 pembrolizumab 5 Radiosurgery 5 Oxaliplatin 5 Bevacizumab 5 130-nm albumin-bound paclitaxel 5 Surgical Procedures, Operative 4 Specimen Handling 4 Secretin 4 Fluorouracil 4 Drug Therapy 4 Ascorbic Acid 4 durvalumab 3 Magnetic Resonance Spectroscopy 3 Leucovorin 3 Irinotecan 3 Cyclophosphamide 3 Cisplatin 3 Biopsy 3 palbociclib 2 methylnaltrexone 2 folfirinox 2 fludarabine 2 entinostat 2 aldesleukin 2 Trastuzumab 2 Standard of Care 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05861336 2024-12-27

OVERPASS

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase 2 Withdrawn

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡